4.7 Article

Predictors of QOL in Patients with Alopecia Areata

Journal

JOURNAL OF INVESTIGATIVE DERMATOLOGY
Volume 142, Issue 10, Pages 2646-+

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jid.2022.02.019

Keywords

-

Categories

Funding

  1. Eli Lilly and Company, United States
  2. Eli Lilly and Company, Indianapolis, Indiana

Ask authors/readers for more resources

Although the severity of alopecia areata (AA) is often determined by the extent of scalp hair loss, its impact on quality of life (QOL) can also be a defining factor. This study found that patients' perception of disease severity, as well as eyelash and eyebrow involvement, were significant predictors of diminished QOL.
Although alopecia areata (AA) severity is often defined by the degree of scalp hair loss, its impact on QOL can also be a defining measure of severity. In this cross-sectional study (AA Disease Specific Program), 259 patients were surveyed for demographics, AA illness characteristics, QOL (Skindex-16 AA), and daily impairment (Work Productivity and Activity Impairment). The association between patient demographics and illness variables, the Skindex-16 AA scores, and the Work Productivity and Activity Impairment scores were analyzed using regression analyses. The mean age of patients was 39 years (51% female). Self-reported severity of current AA was rated as mild (21%), moderate (54%), and severe (25%). The highest impairment was observed for the Skindex-16 AA emotions and the Work Productivity and Activity Impairment daily activity performance scores. Although the degree of scalp hair loss (physician Severity of Alopecia Tool score) was not predictive of QOL, patients' self-report of moderate or severe disease, sex (females more impacted), and eyebrow and eyelash involvement were predictors of diminished QOL, consistently and incrementally. The present results suggest patients' perception of severity as well as the presence of eyelash and eyebrow hair loss are also impactful and should be considered in defining the severity of disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available